The expression of cleaved caspase-9 and cleaved caspase-3 proteins increased by 165% and 161%, respectively (p < 0.05), in the CDDP treatment group compared to the tumor group, but these increases were significantly (p < 0.05) lower than those observed in the RTP-H treatment group. This evidence concerns the gene CASP3 and neoplasm.